Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2022-09-01 00:00:00 ET · period of report 2022-08-30 · accession 0000899243-22-030186 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-01 | 2022-08-30 | TCRT | Boyle Kevin S. Sr. | CEO, Dir | F - Tax | $2.41 | -18.8K | 866.2K | -2% | -$45.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-30 | F | D | 18,750 | $2.41 | 866,250 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligations in connection with the vesting of shares of restricted stock previously granted to the Reporting Person. |